// App-Quantinova.ai

3273 : The efficiency of anti-tumor effect of metformin for gemcitabine-resistant pancreatic adenocarcinoma

Researchers

Presenter

  • Keiichi Suzuki

Principal Investigators

  • Osamu Takeuchi

  • Yoshiyuki Ishii

  • Masayoshi Osaku

Medical Centers

  • Kitasato Institute Hospital, Tokyo, Japan.

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreas ductal adenocarcinoma

  • Pancreatic cancer

  • Type 2 diabetes mellitus

  • Diabetes

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Gemcitabine

  • Metformin Hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved